TransEnterix (TRXC) Granted US 510(k) FDA Clearance for Senhance Surgical Robotic System
Tweet Send to a Friend
TransEnterix, Inc. (NYSE: TRXC) today announced the Company has received FDA 510(k) clearance for the Senhance™ Surgical Robotic System.“The clearance ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
